Tumors from the Lenti-li-DT-KRAS G12D -treated mice contained a higher density of CD45 + hematopoietic cells than those from their Ctrl Lenti-treated counterparts, even if the difference did not reach statistical significance (Fig. 3 D, E ).
← all excerpts
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy.
1
—
—